United States - English - NLM (National Library of Medicine)

remedyrepack inc. - medroxyprogesterone acetate (unii: c2qi4ioi2g) (medroxyprogesterone - unii:hsu1c9yres) - medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. limitations of use : the use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see  dosage and administration (2.1)and warnings and precautions (5.1)]. the use of medroxyprogesterone acetate injectable suspension is contraindicated in the following conditions: - known or suspected pregnancy or as a diagnostic test for pregnancy. - active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease [see warnings and precautions (5.2)]. - known or suspected malignancy of breast [see warnings and precautions (5.3)] . - known hypersensitivity to medroxyprogesterone acetate injectable suspension or any of its other ingredients [see

United States - English - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - medroxyprogesterone acetate (unii: c2qi4ioi2g) (medroxyprogesterone - unii:hsu1c9yres) - medroxyprogesterone acetate tablets, usp are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. they are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets. medroxyprogesterone acetate is contraindicated in women with any of the following conditions: - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - known or suspected estrogen- or progesterone-dependent neoplasia. - active dvt, pe, or a history of these conditions - active arterial thromboembolic disease (for example, stroke and mi), or a history of these conditions. - known anaphylactic reaction or angioedema to medroxyprogesterone acetate. - known liver impairment or disease. - known or suspected pregnancy.

Canada - English - Health Canada

pfizer canada ulc - medroxyprogesterone acetate - suspension - 150mg - medroxyprogesterone acetate 150mg - progestins

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - medroxyprogesterone acetate, quantity: 2.5 mg - tablet, uncoated - excipient ingredients: sunset yellow fcf; maize starch; lactose monohydrate; purified talc; liquid paraffin; calcium stearate; sucrose - 1.carcinoma: palliative treatment of recurrent and/or metastatic breast or renal cell cancer and of inoperable recurrent or metastatic endometrial carcinoma. 2.endometriosis: for use in the treatment of visually proven (laparoscopy) endometriosis where the required end-point of treatment is pregnancy, or for the control of symptoms when surgery is contraindicated or has been unsuccessful. 3. secondary amenorrhoea proven not due to pregnancy: in amenorrhoea associated with a poorly developed proliferative endometrium, conventional oestrogen therapy may be employed in conjunction with medroxyprogesterone acetate. 4. abnormal uterine bleeding, in the absence of organic pathology. 5. adjunct to oestrogen therapy.

Canada - English - Health Canada

pfizer canada ulc - medroxyprogesterone acetate - suspension - 150mg - medroxyprogesterone acetate 150mg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - medroxyprogesterone acetate - orange tablet, diameter: 6.5 mm, thickness: 2.7 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

fuji pharmaceutical co.,ltd. - medroxyprogesterone acetate - white tablet, diameter: 9.0 mm, thickness: 3.3 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

fuji pharmaceutical co.,ltd. - medroxyprogesterone acetate - white tablet with split line, diameter: 7.0 mm, thickness: 2.3 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

fuji pharmaceutical co.,ltd. - medroxyprogesterone acetate - white tablet with split line, diameter: 7.0 mm, thickness: 2.3 mm

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - medroxyprogesterone acetate - injection - 50 mg/ml - medroxyprogesterone acetate 50 mg/ml